https://www.selleckchem.com/pr....oducts/polyinosinic-
This article is about new prospects for incretin-related drugs in the treatment of type 2 diabetes.Base-editing technologies enable the introduction of point mutations at targeted genomic sites in mammalian cells, with higher efficiency and precision than traditional genome-editing methods that use DNA double-strand breaks, such as zinc finger nucleases (ZFNs), transcription-activator-like effector nucleases (TALENs), and the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associate
Like
Comment
Share
